A carregar...
Infliximab enhances the therapeutic effects of 5-fluorouracil resulting in tumor regression in colon cancer
Colon cancer (CC) is among the most common malignant diseases with a dismal survival. Tumor necrosis factor-alpha (TNF-α) has been identified as a therapeutic target in various cancers, and anti-TNF-α treatment has shown promising effects in different cancer models. However, if TNF-α can be targeted...
Na minha lista:
| Publicado no: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5055041/ https://ncbi.nlm.nih.gov/pubmed/27757041 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S109342 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|